SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-18-050143
Filing Date
2018-02-20
Accepted
2018-02-20 14:47:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC TO-C d528796dsctoc.htm SC TO-C 16216
2 EX-99.1 d528796dex991.htm EX-99.1 14100
3 GRAPHIC g528796img01.jpg GRAPHIC 37516
4 GRAPHIC g528796img02.jpg GRAPHIC 10768
  Complete submission text file 0001193125-18-050143.txt   98800
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Subject) CIK: 0001617582 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90201 | Film No.: 18624236
SIC: 2836 Biological Products, (No Diagnostic Substances)